May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
A Comparison of 3–Day versus 1–Hour Prophylaxis With Gatifloxacin 0.3% Prior to Cataract Surgery
Author Affiliations & Notes
  • S.E. Pascucci
    Ophthalmology, Florida Eye Health, Ft Myers, FL
  • Footnotes
    Commercial Relationships  S.E. Pascucci, Allergan, Inc. F, C, R; Refractec F, R; Bausch & Lomb R.
  • Footnotes
    Support  Allergan
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 794. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      S.E. Pascucci; A Comparison of 3–Day versus 1–Hour Prophylaxis With Gatifloxacin 0.3% Prior to Cataract Surgery . Invest. Ophthalmol. Vis. Sci. 2005;46(13):794.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To determine the efficacy of 3–day versus 1–day topical gatifloxacin therapy in bacterial flora reduction in patients undergoing cataract surgery. Methods: A total of 50 patients participated in an evenly randomized prospective clinical trial. All patients received gatifloxacin 0.3% (Zymar®, Allergan. Inc. Irvine, CA) in the eye to receive surgery 1 hour prior to surgery as well as a standard 5% povidone iodine surgical prep. A subset of these patients (n = 25) received additional gatifloxacin 0.3% therapy for 3 days prior to surgery, and were considered to be in the study group. The other 25 patients that did not receive the 3–day dosing regimen were considered to be in the control group. Results: Thirty–two percent (8/25) of the patients (eyes) in the control (1–hour) group had positive conjunctival cultures when performed right before cataract surgery in comparison to 20 percent (5/25) in the study (3–day) group. In the time frame which immediately followed surgery, 20 percent (5/25) had positive cultures in the control group versus 12 percent (3/25) in the study group. Conclusions: Topical gatifloxacin 0.3% administration for 3–days prior to cataract surgery was more effective at conjunctival bacterial colony reduction in comparison to 1–hour pre–procedural administration. Three–day administration appears to be helpful at reducing the presence of bacteria in the operative field during the preoperative period.

Keywords: antibiotics/antifungals/antiparasitics • cataract • bacterial disease 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×